14th Oporto ILD Meeting
5th OF JUNE 2025 (Thursday)
CIM-FMUP AUDITORIUM
The scheduled program is set according to the Portuguese Time Zone (GMT)
08:45Welcome
Hot Topics in Connective Tissue Disease-Associated Interstitial Lung Disease
09h00CTD-ILD: What Truly Drives Outcomes – The Underlying Disease, Clinical Presentation, or Imaging Pattern?
Claudia Ravaglia
Department of Medical and Surgical Sciences (DIMEC), Bologna University, Pulmonology Unit, G.B. Morgagni Hospital, Forlì, Italy
09h30Immunosuppressive Strategy in CTD-ILD: Monotherapy, Combination Therapy, or Sequential Approach?
Elisabetta Renzoni
Interstitial Lung Disease Unit, Department of Imaging, Royal Brompton Hospital, London, United Kingdom
10h00Progressive pulmonary fibrosis in CTD-ILD: early diagnosis and management
Sara Tomassetti
Department of Clinical and Experimental Medicine Careggi University Hospital Florence, Italy
10h30Navigating Pulmonary Hypertension in Systemic Sclerosis: Clinical Implications and Management Strategies
Lucilla Piccari
Department of Pulmonology Hospital del Mar, Barcelona, Spain
11h00Coffee Break
Controversies in Drug-Induced Lung Disease
11h30Drug-Induced ILD: A Comprehensive Approach to Diagnosis and Treatment
Venerino Poletti
Department of Medical and Surgical Sciences (DIMEC), Bologna University, Pulmonology Unit, G.B. Morgagni Hospital, Forlì, Italy; Department of Respiratory Diseases & Allergy, Aarhus University, Aarhus, Denmark
12h00Managing Drug-Induced ILD in Lung Cancer Treatment: Challenges and Clinical Approaches
Philippe Bonniaud
Department of Pulmonary Medicine and Intensive Care Unit, University Hospital of Dijon, 2 Bd; Maison de L’Université, Esp. Erasme, 21078, Dijon, France; Bourgogne Franche-Comté University
12h30Drug-Induced Lung Disease and Acute Pneumonia: Pathogenesis, Diagnosis, and Treatment Considerations
Philippe Bonniaud
13h00Lunch
Familial Pulmonary Fibrosis diagnosis and management
14h00Familial Pulmonary Fibrosis With and Without Genetic Variants: Are Diagnostic and Management Strategies Different?
Elizabetta Renzoni
14h30Is there a different approach in the diagnosis and management of Familial Pulmonary Fibrosis with and without an identified genetic association?
Raphael Borie
Hôpital Bichat, APHP, Service de Pneumologie A, Centre constitutif du centre de référence des Maladies Pulmonaires Rares, FHU APOLLO, Paris, France; Université Paris Cité, Inserm, PHERE, Paris, France
15h00Different expressions of Familial Pulmonary Fibrosis - is there any differences?
Cláudia Valenzuela
ILD Unit, Pulmonology Department, Hospital Universitario de la Princesa, University Autonomade Madrid, Madrid, Spain
15h30Coffee Break
Rare Diffuse Lung Disorders Corner
16h30European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosis
Cormac McCarthy
School of Medicine, University College Dublin, Dublin, Ireland
17h00New trends in Niemann – Pick Disease
Tarekegn Geberhiwot
Department of Diabetes, Endocrinology and Metabolism, University Hospital Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK; Institute of Metabolism and System Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK
17h30Childhood interstitial lung disease survivors in adulthood – the best approach and how to manage
Raphael Borie
6th OF JUNE 2025 (Friday)
CIM-FMUP AUDITORIUM
The scheduled program is set according to the Portuguese Time Zone (GMT)
Fibrotic Interstitial Lung Diseases Traits
09h00PF: What Has Changed with Antifibrotic Therapy?
Sara Tomassetti
09h30The clinical meaning of the UIP pattern on cryobiopsy
Venerino Poletti
10h00ANCA-Associated Interstitial Lung Disease: Presentation, Progression, and Treatment Strategies
Cláudia Valenzuela
10h30Nerandumilast, the beginning of a new era in fibrotic ILDs?
Vincent Cottin
National Coordinating Reference Centre for Rare Pulmonary Diseases, Department of Respiratory Medicine, Louis Pradel Hospital, Hospices Civils de Lyon, ERN-LUNG, UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France
11h00Coffee Break
Challenges in Chronic Sarcoidosis
11h30Fibrotic Sarcoidosis: Diverse Phenotypes and Tailored Management Strategies
Claudia Ravaglia
12h00Chronic infection in fibrotic sarcoidosis
Hilário Nunes
Pneumology Department, Avicenne Hospital, Paris, France
12h30Diagnostic and Management of Cardiac Sarcoidosis: A Scientific Statement from the American Heart Association
Richard K Cheng
Division of Cardiology, Department of Medicine University of Washington Seattle WA USA
13h00Navigating Sarcoidosis-Associated PH: Risk Factors, Recognition, and Treatment Options
Hilário Nunes
